Literature DB >> 25795284

Homozygous mutations in the SCN1A gene associated with genetic epilepsy with febrile seizures plus and Dravet syndrome in 2 families.

Andreas Brunklaus1, Rachael Ellis2, Helen Stewart3, Sarah Aylett4, Eleanor Reavey2, Ros Jefferson5, Rakesh Jain6, Supratik Chakraborty7, Sandeep Jayawant6, Sameer M Zuberi8.   

Abstract

BACKGROUND: Mutations in the gene encoding the alpha subunit of the voltage-gated sodium channel SCN1A are associated with several epilepsy syndromes. These range from severe phenotypes including Dravet syndrome to milder phenotypes such as genetic epilepsy with febrile seizures plus (GEFS+). To date the sequence variants identified have been heterozygous in nature as one would expect for a disorder that occurs de novo or is dominantly inherited. METHODS AND
RESULTS: We report the association of two novel homozygous missense mutations of the SCN1A gene in four children with infantile epilepsies from two consanguineous pedigrees. We suggest that the nature and location of the identified amino acid changes allows heterozygous carriers to remain unaffected. However, having such changes on both alleles may have a cumulative and detrimental effect.
CONCLUSION: The presented cases illustrate how better understanding of the nature and location of SCN1A missense mutations may aid the interpretation of genotype-phenotype associations. SCN1A related epilepsies should be considered in children with infantile onset epilepsies even when an autosomal recessive neurological disorder is suspected.
Copyright © 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dravet syndrome; Febrile seizures; GEFS+; SCN1A; Severe myoclonic epilepsy of infancy

Mesh:

Substances:

Year:  2015        PMID: 25795284     DOI: 10.1016/j.ejpn.2015.02.001

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  6 in total

1.  A novel homozygous mutation in SZT2 gene in Saudi family with developmental delay, macrocephaly and epilepsy.

Authors:  Muhammad Imran Naseer; Mohammad Khalid Alwasiyah; Angham Abdulrahman Abdulkareem; Rayan Abdullah Bajammal; Carlos Trujillo; Muhammad Abu-Elmagd; Mohammad Alam Jafri; Adeel G Chaudhary; Mohammad H Al-Qahtani
Journal:  Genes Genomics       Date:  2018-02-28       Impact factor: 1.839

2.  Phenotypic and Genotypic Characteristics of SCN1A Associated Seizure Diseases.

Authors:  Chunhong Chen; Fang Fang; Xu Wang; Junlan Lv; Xiaohui Wang; Hong Jin
Journal:  Front Mol Neurosci       Date:  2022-04-28       Impact factor: 5.639

3.  Case Report: Novel Homozygous Likely Pathogenic SCN1A Variant With Autosomal Recessive Inheritance and Review of the Literature.

Authors:  Ana Victoria Marco Hernández; Miguel Tomás Vila; Alfonso Caro Llopis; Sandra Monfort; Francisco Martinez
Journal:  Front Neurol       Date:  2021-11-30       Impact factor: 4.003

Review 4.  Fever-Associated Seizures or Epilepsy: An Overview of Old and Recent Literature Acquisitions.

Authors:  Piero Pavone; Xena Giada Pappalardo; Enrico Parano; Raffaele Falsaperla; Simona Domenica Marino; John Kane Fink; Martino Ruggieri
Journal:  Front Pediatr       Date:  2022-04-21       Impact factor: 3.569

5.  De novo homozygous variant of the SCN1A gene in a patient with severe Dravet syndrome complicated by acute encephalopathy.

Authors:  Le Thi Khanh Van; Huynh Thi Dieu Hien; Huynh Thi Thuy Kieu; Nguyen Le Trung Hieu; Le Sy Vinh; Giang Hoa; Do Thi Thu Hang
Journal:  Neurogenetics       Date:  2021-03-05       Impact factor: 2.660

6.  The Genetic Diagnosis of Ultrarare DEEs: An Ongoing Challenge.

Authors:  Luciana Musante; Paola Costa; Caterina Zanus; Flavio Faletra; Flora M Murru; Anna M Bianco; Martina La Bianca; Giulia Ragusa; Emmanouil Athanasakis; Adamo P d'Adamo; Marco Carrozzi; Paolo Gasparini
Journal:  Genes (Basel)       Date:  2022-03-12       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.